Publications

Detailed Information

Hepatic progenitor cells in liver cancers from Asian children

DC Field Value Language
dc.contributor.authorWard, Stephen C.-
dc.contributor.authorThung, Swan N.-
dc.contributor.authorLim, Kiat Hon-
dc.contributor.authorTran, Tung Thanh-
dc.contributor.authorHoang, Phuc Le-
dc.contributor.authorPark, Young Nyun-
dc.contributor.authorAbe, Kenji-
dc.contributor.authorJang, Ja June-
dc.contributor.authorHong, Thi Khang Bui-
dc.date.accessioned2012-06-01T07:59:03Z-
dc.date.available2012-06-01T07:59:03Z-
dc.date.issued2010-01-
dc.identifier.citationLIVER INTERNATIONAL; Vol.30 1; 102-111ko_KR
dc.identifier.issn1478-3223-
dc.identifier.urihttps://hdl.handle.net/10371/76725-
dc.description.abstractBackground/Aims Hepatoblastoma (HB) and hepatocellular carcinoma (HCC) are the two most common primary malignant liver tumours in children. Hepatic progenitor cells have been described and can be stained with K19, EpCAM and CD117. We investigated the morphology and staining patterns of primary liver tumours in Asian children. Methods Four pathologists studied slides from 39 paediatric patients from Vietnam and Korea aged 8 months to 16 years. We performed immunohistochemical stains for K19, EpCAM and CD117, and polymerase chain reaction for tissue hepatitis B virus (HBV) DNA and hepatitis C virus (HCV) RNA. Results There was agreement on the diagnosis of 24 cases of HCC and 10 cases of HB (one recurrent case). The diagnosis was split for six cases (HCC/HB). All 20 cases of HCC tested were HBV DNA+ and HCV RNA-. All nine cases of HB tested were HBV DNA-, while one was HCV RNA+. Of four HCC/HB cases tested, three were HBV DNA+ and all were HCV RNA-. By immunohistochemistry, 8/24 (33%) cases of HCC were K19+ and 18/24 (75%) were EpCAM+, 5/10 (50%) cases of HB were K19+ and 7/10 (70%) were EpCAM+ and 3/6 (50%) cases of HCC/HB were K19+ and 5/6 (83%) were EpCAM+. CD117 was negative in all 38 cases tested. Paediatric HCC has a morphology different from adult HCC, sometimes resembling HB, and a larger proportion of paediatric tumours have progenitor cell features. Conclusions HB and HCC in children may represent malignant transformation at an early stage in the cellular lineage and often arise from hepatic progenitor cells.ko_KR
dc.language.isoenko_KR
dc.publisherWILEY-BLACKWELL PUBLISHING, INCko_KR
dc.subjectCK19ko_KR
dc.subjecthepatic stem cellsko_KR
dc.subjectpaediatric hepatocellular carcinomako_KR
dc.subjecthepatoblastomako_KR
dc.subjecthepatic progenitor cellsko_KR
dc.subjectEpCAMko_KR
dc.titleHepatic progenitor cells in liver cancers from Asian childrenko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor장자준-
dc.contributor.AlternativeAuthor박영년-
dc.identifier.doi10.1111/j.1478-3231.2009.02126.x-
dc.citation.journaltitleLIVER INTERNATIONAL-
dc.description.citedreferenceFinegold MJ, 2008, LIVER TRANSPLANT, V14, P1545, DOI 10.1002/lt.21654-
dc.description.citedreferenceVillanueva A, 2008, HEPATOLOGY, V48, p361A-
dc.description.citedreferenceMoore SW, 2008, WORLD J SURG, V32, P1389, DOI 10.1007/s00268-008-9526-8-
dc.description.citedreferenceYang XR, 2008, CLIN CANCER RES, V14, P3850, DOI 10.1158/1078-0432.CCR-07-4338-
dc.description.citedreferenceZhuang PY, 2008, CANCER, V112, P2740, DOI 10.1002/cncr.23488-
dc.description.citedreferenceSell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945-
dc.description.citedreferenceMao L, 2008, TRANSPL P, V40, P1635, DOI 10.1016/j.transproceed.2008-03-133-
dc.description.citedreferenceSpector LG, 2008, BRIT J CANCER, V98, P1570, DOI 10.1038/sj.bjc.6604335-
dc.description.citedreferenceKomuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238-
dc.description.citedreferenceNguyen VTT, 2008, LIVER INT, V28, P525, DOI 10.1111/j.1478-3231.2007.01646.x-
dc.description.citedreferenceYamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013-
dc.description.citedreferenceIshimura M, 2007, PEDIATR TRANSPLANT, V11, P945, DOI 10.1111/j.1399-3046.2007.00802.x-
dc.description.citedreferenceIsaacs H, 2007, J PEDIATR SURG, V42, P1797, DOI 10.1016/j.jpedsurg.2007.07.047-
dc.description.citedreferenceMeyers RL, 2007, SURG ONCOL, V16, P195, DOI 10.1016/j.suronc.2007.07.002-
dc.description.citedreferenceTrzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152-
dc.description.citedreferenceMa S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025-
dc.description.citedreferenceBecker G, 2007, CLIN ONCOL-UK, V19, P204, DOI 10.1016/j.clon.2006.12.009-
dc.description.citedreferenceDurnez A, 2006, HISTOPATHOLOGY, V49, P138, DOI 10.1111/j.1365-2559.2006.02468.x-
dc.description.citedreferenceLee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377-
dc.description.citedreferenceFiegel HC, 2004, J HISTOCHEM CYTOCHEM, V52, P1495, DOI 10.1369/jhc.4A6297.2004-
dc.description.citedreferenceDavies JQ, 2004, J PEDIATR SURG, V39, P1321, DOI 10.1016/j.jpedsurg.2004.05.020-
dc.description.citedreferenceRoskams TA, 2004, HEPATOLOGY, V39, P1739-
dc.description.citedreferenceKim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053-
dc.description.citedreferenceDarbari A, 2003, HEPATOLOGY, V38, P560, DOI 10.1053/jhep.2003.50375-
dc.description.citedreferenceTheise ND, 2003, HISTOPATHOLOGY, V43, P263-
dc.description.citedreferenceBadve S, 2003, MODERN PATHOL, V16, P930, DOI 10.1097/01.MP.0000086486.52370.81-
dc.description.citedreferenceDavila JA, 2003, J CLIN EPIDEMIOL, V56, P487, DOI 10.1016/S0895-4356(02)00605-4-
dc.description.citedreferenceKew MC, 2002, TOXICOLOGY, V181, P35-
dc.description.citedreferenceProkurat A, 2002, MED PEDIATR ONCOL, V39, P510, DOI 10.1002/mpo.10177-
dc.description.citedreferenceLee DH, 2002, J KOREAN MED SCI, V17, P457-
dc.description.citedreferenceSchnater JM, 2002, CANCER, V94, P1111, DOI 10.1002/cncr.10282-
dc.description.citedreferenceInagaki M, 2001, EUR J GASTROEN HEPAT, V13, P981-
dc.description.citedreferenceISHAK KG, 2001, TUMORS LIVER INTRAHE, P159-
dc.description.citedreferenceRuck P, 2000, J PATHOL, V191, P102-
dc.description.citedreferenceWei Y, 2000, ONCOGENE, V19, P498-
dc.description.citedreferenceTheise ND, 1999, HEPATOLOGY, V30, P1425-
dc.description.citedreferenceLegoix P, 1999, ONCOGENE, V18, P4044-
dc.description.citedreferenceTsuji M, 1999, PATHOL INT, V49, P310-
dc.description.citedreferenceBosch FX, 1999, SEMIN LIVER DIS, V19, P271-
dc.description.citedreferenceRoskams T, 1998, J HEPATOL, V29, P455-
dc.description.citedreferenceAbe K, 1998, HEPATOLOGY, V28, P568-
dc.description.citedreferenceRobrechts C, 1998, LIVER, V18, P288-
dc.description.citedreferencede La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847-
dc.description.citedreferenceRuck P, 1997, HISTOPATHOLOGY, V31, P324-
dc.description.citedreferenceRuck P, 1996, HISTOPATHOLOGY, V29, P590-
dc.description.citedreferenceHaque S, 1996, LAB INVEST, V75, P699-
dc.description.citedreferenceJaskiewicz K, 1995, ANTICANCER RES, V15, P2723-
dc.description.citedreferenceCHEN TC, 1995, J PATHOL, V176, P243-
dc.description.citedreferenceNG IOL, 1995, J GASTROEN HEPATOL, V10, P250-
dc.description.citedreferenceWEE A, 1995, J CLIN PATHOL, V48, P236-
dc.description.citedreferenceFINEGOLD MJ, 1994, SEMIN LIVER DIS, V14, P270-
dc.description.citedreferenceSAEGUSA M, 1993, J CANCER RES CLIN, V119, P737-
dc.description.citedreferenceHANABATA M, 1991, KOBE J MED SCI, V37, P81-
dc.description.citedreferenceSELL S, 1989, AM J PATHOL, V134, P1347-
dc.description.citedreferenceWEINBERG AG, 1986, PATHOLOGY NEOPLASIA, P333-
dc.description.citedreferenceGERBER MA, 1983, AM J PATHOL, V110, P70-
dc.description.citedreferenceFARBER E, 1963, ADV CANCER RES, V7, P383-
dc.description.tc6-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share